<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1625100</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2025.1625100</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Prevalence of kidney stones based on metabolic health and weight criteria: reports from the national health and nutrition examination survey 2007-2018 data analysis</article-title>
<alt-title alt-title-type="left-running-head">Ding et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1625100">10.3389/fphys.2025.1625100</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Xijie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Qingchen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jianxing</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Chaoyue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Endi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hu</surname>
<given-names>Weiguo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3060947/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Urology</institution>, <institution>Qinghai University Affiliated Hospital</institution>, <institution>School of Clinical Medicine</institution>, <institution>Qinghai University</institution>, <addr-line>Xining</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Urology</institution>, <institution>Beijing Tsinghua Changgung Hospital</institution>, <institution>School of Clinical Medicine</institution>, <institution>Tsinghua University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/604903/overview">Dulce Elena Casarini</ext-link>, Federal University of S&#xe3;o Paulo, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1457790/overview">Guangyuan Zhang</ext-link>, Southeast University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1508589/overview">Banghua Liao</ext-link>, Sichuan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1567575/overview">Xudong Shen</ext-link>, First Affiliated Hospital of Anhui Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Weiguo Hu, <email>weiguohu2006@126.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1625100</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Ding, Du, Li, Ji, Zhang and Hu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Ding, Du, Li, Ji, Zhang and Hu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>Using data from the NHANES collected between 2007-2018, this study aimed to investigate the relationship between the prevalence of kidney stones and metabolically healthy obesity (MHO) and measure the effect of physical activity as a modifying factor.</p>
</sec>
<sec>
<title>Methods</title>
<p>This cross-sectional analysis included 12,498 participants aged &#x2265;20 years who were categorized into six groups based on their metabolic status (healthy or unhealthy) and BMI (normal, overweight, and obesity). Kidney stone history was self-reported. Weighted logistic regression models, adjusted for demographic characteristics, comorbidities, and lifestyle variables, were applied to calculate odds ratios and 95% confidence intervals. Subgroup analyses were conducted based on the degree of physical activity.</p>
</sec>
<sec>
<title>Results</title>
<p>The overall prevalence of kidney stones was 10.20%. Participants with metabolically unhealthy obesity (MUO) had the highest prevalence of kidney stones (14.5%), followed by individuals with MHO (11.1%). After full adjustment, compared to participants with MHN, the MHO and MUO groups exhibited significantly greater risks of kidney stones (MHO: OR &#x3d; 2.10, 95% CI:1.47&#x2013;2.98, P &#x3c; 0.001; MUO: OR &#x3d; 1.98, 95% CI:1.45&#x2013;2.67, P &#x3c; 0.001). Physical activity was associated with a decreased risk of kidney stones, particularly among individuals with MUO. Stratified analyses revealed no significant interaction effects by age, sex, or race.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Obesity, irrespective of metabolic health status, was significantly associated with a higher prevalence of kidney stones. Higher levels of physical activity were correlated with lower risks of kidney stones, particularly in metabolically unhealthy individuals. These results underscore the importance of managing body weight and maintaining physical activity as key strategies to prevent kidney stones.</p>
</sec>
</abstract>
<kwd-group>
<kwd>metabolically healthy obesity</kwd>
<kwd>metabolic syndrome</kwd>
<kwd>obesity</kwd>
<kwd>kidney stones</kwd>
<kwd>physical activity</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Renal Physiology and Pathophysiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Background</title>
<p>Urolithiasis is a common urological condition whose prevalence has increased worldwide over the past few decades (<xref ref-type="bibr" rid="B21">Peerapen and Thongboonkerd, 2023</xref>). It imposes a substantial financial burden on healthcare systems. In the United States, more than $2 billion is invested annually for treating urolithiasis (<xref ref-type="bibr" rid="B25">Thongprayoon et al., 2020</xref>). With the concurrent increase in the incidence of metabolic abnormalities, such as diabetes and obesity, the prevalence of kidney stones has increased (<xref ref-type="bibr" rid="B29">Wong et al., 2016</xref>; <xref ref-type="bibr" rid="B18">Moftakhar et al., 2022</xref>). With the rapid increase in the number of individuals with obesity in the United States, the incidence of kidney stones is steadily increasing, and the prevalence of kidney stones disease is nearly 20% in high-risk groups (<xref ref-type="bibr" rid="B17">Menke et al., 2015</xref>). Therefore, elucidating the risk factors linking these conditions is crucial for the effective management of kidney stones.</p>
<p>Obesity is strongly associated with metabolic abnormalities (<xref ref-type="bibr" rid="B22">Schulze and Stefan, 2024</xref>; <xref ref-type="bibr" rid="B3">Alexander et al., 2022</xref>), but a distinct subgroup of obese individuals exhibits few or no metabolic abnormalities, a state known as MHO (<xref ref-type="bibr" rid="B11">Kramer et al., 2013</xref>). Importantly, accumulating evidence indicates that individuals with MHO exhibit a significantly lower cardiometabolic risk compared to those with MUO (<xref ref-type="bibr" rid="B11">Kramer et al., 2013</xref>; <xref ref-type="bibr" rid="B7">Eckel et al., 2018</xref>). This metabolic heterogeneity suggests that body mass index (BMI) alone is not enough to assess obesity-related health risks. Although obesity, often measured based on BMI, and associated metabolic syndrome is an established risk factor for nephrolithiasis (<xref ref-type="bibr" rid="B13">Lin et al., 2020</xref>; <xref ref-type="bibr" rid="B14">Lo et al., 2023</xref>; <xref ref-type="bibr" rid="B10">Ferraro et al., 2024</xref>), the effect of the MHO phenotype on the risk of nephrolithiasis remains poorly understood. Investigating MHO, rather than BMI alone, is crucial because it allows us to assess the potential effects of metabolic health status on the risk of nephrolithiasis among individuals with obesity. Carefully designed studies assessing the relationship between MHO and kidney stones can help determine the risk of nephrolithiasis among obese individuals, thereby guiding preventive interventions.</p>
<p>This study aimed to explore the link between MHO and nephrolithiasis by analyzing data from NHANES. Furthermore, elucidating the protective effect of physical activity on nephrolithiasis in subjects with metabolic abnormality may have significant implications for the development of specific preventive and therapeutic strategies.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Data source and participants</title>
<p>The core data for this study were obtained from the NHANES database, which is managed by the U.S. Centers for Disease Control and Prevention. The NHANES employs a sophisticated probability sampling method every 2 years to collect data reflecting the U.S. population, encompassing details on demographics, socioeconomic conditions, dietary habits, and health-related factors.</p>
</sec>
<sec id="s2-2">
<title>2.2 Population</title>
<p>This study used data from six NHANES data cycles spanning 2007-2018. The inclusion criteria were as follows: (1) individuals aged 20 years or older; (2) participants providing full details on BMI, metabolic syndrome, and history of kidney stones; and (3) availability of data regarding physical activity and additional covariates. The exclusion criteria were as follows: (1) age &#x3c;20 years; (2) missing data regarding the diagnosis of kidney stone or metabolic health status; (3) incomplete covariate data, e.g., age, sex, and BMI. After applying these criteria, the final sample consisted of 12,498 participants (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Flow diagram of participant screening. NHANES.</p>
</caption>
<graphic xlink:href="fphys-16-1625100-g001.tif">
<alt-text content-type="machine-generated">Flowchart detailing participant selection for NHANES 2007&#x2d;2018 study. Starts with 59,842 participants. Excludes 25,072 under 20 years and 20,794 with missing kidney stones or metabolic data. Further removes 1,478 due to missing covariates, resulting in 12,498 participants for analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-3">
<title>2.3 Exposures and outcomes</title>
<p>Kidney stones: The main focus of this study was to determine the incidence of kidney stones, evaluated using data from the Questionnaire (question KIQ026): &#x201c;Have you ever experienced kidney stones?&#x201d; Individuals who answered affirmatively were categorized as having a &#x201c;kidney stone.&#x201d; (<xref ref-type="bibr" rid="B12">Li et al., 2024</xref>).</p>
<p>Metabolic syndrome was defined based on the 2009 criteria (<xref ref-type="bibr" rid="B2">Alberti et al., 2009</xref>). Individuals meeting at least three of the following five criteria were considered to have metabolic syndrome: (1) triglyceride levels more than1.7 mmol/L or reliance on lipid-lowering medications; (2) reduced HDL-C levels, less than 1.0 mmol/L in men or 1.3 mmol/L in women, or use of cholesterol-lowering drugs; (3) elevated blood pressure (systolic &#x2265;130 mm Hg and/or diastolic &#x2265;85 mm Hg), or using antihypertensive drugs; (4) fasting blood glucose levels of 5.6 mmol/L or higher, a self-reported diabetes diagnosis, or use of glucose-lowering treatments; (5) elevated waist circumference (&#x2265;102 cm in men; &#x2265;88 cm in women).</p>
<p>BMI was determined based on the examination data and calculated by dividing body mass in kilograms by the square of height in meters. According to World Health Organization (WHO) guidelines, participants were categorized into three groups: normal weight (18.5&#x2013;24.9 kg/m<sup>2</sup>), overweight (25.0&#x2013;29.9 kg/m<sup>2</sup>), and obese (&#x3e;30 kg/m<sup>2</sup>) (<xref ref-type="bibr" rid="B8">Elmaleh-Sachs et al., 2023</xref>).</p>
<p>Using the combination of metabolic syndrome status and BMI categories, participants were divided into six groups: MHN: metabolically healthy normal weight, MHOW: metabolically healthy overweight, MHO: metabolically healthy obese, MUN: metabolically unhealthy normal weight, MUOW: metabolically unhealthy overweight, and MUO: metabolically unhealthy obese.</p>
</sec>
<sec id="s2-4">
<title>2.4 Covariates</title>
<p>To account for potential confounding factors, the model was adjusted for several demographic and health-related variables, including education level, sex, age, race, family income-to-poverty ratio (FIR), smoking status, coronary heart disease, gout, and physical activity. A comprehensive summary of these covariates can be found in <xref ref-type="sec" rid="s12">Supplementary Table S1</xref> (available in <xref ref-type="sec" rid="s12">Supplementary Digital Content 1</xref>).</p>
<p>Physical activity included both moderate and vigorous activities. Moderate physical activity was defined as engagement in work-related or recreational activities lasting &#x2265;10 min per week, accompanied by small increases in the heart rate or breathing (e.g., brisk walking, recreational volleyball, or swimming). Vigorous physical activity included activities that largely increased the heart rate or breathing (e.g., carrying heavy loads, running, competitive basketball, or construction work) for &#x2265;10 min weekly (<xref ref-type="bibr" rid="B12">Li et al., 2024</xref>). Since more physical activity may reduce the risk of kidney stones (<xref ref-type="bibr" rid="B16">Mao et al., 2022</xref>), we conducted a logistic regression analysis, stratified by participants&#x2019; physical activity levels, to more precisely assess the association between MHO and the risk of developing kidney stones.</p>
</sec>
<sec id="s2-5">
<title>2.5 Statistical analysis</title>
<p>This study followed the statistical analysis protocols established by the Centers for Disease Control and Prevention (CDC), incorporating appropriate sample weights for participant selection. The baseline characteristics of the study population were outlined based on metabolic status and BMI. Continuous variables are presented as mean &#xb1; standard deviations (SD), and categorical variables are expressed as percentages (%). Survey-weighted Analysis of Variance (ANOVA) was applied to evaluate differences in continuous variables across the six metabolic-BMI groups, and survey-weighted &#x3c7;<sup>2</sup> tests were employed for categorical variables. Logistic regression analyses were used to assess the association between MHO and kidney stones, using both unadjusted (Model 1) and adjusted models. Model 1 was unadjusted; Model 2 was adjusted for sex, age, and race; and Model 3 was further adjusted for participant factors, including education level, FIR, smoking status, coronary heart disease, and physical activity. The magnitude of the association was determined using odds ratios (ORs) with corresponding 95% confidence intervals. Interaction effects were measured using stratified logistic regression analyses to investigate potential interactions between covariates, assess the association of MHO with kidney stones, and confirm the consistency of the findings. This approach aimed to identify the factors modifying the association between MHO and kidney stones within subgroups of physical activity. Statistical analyses were conducted using R software (developed by The R Foundation) and STATA 16.0 (produced by Stata Corporation, located in College Station, TX, USA), A two-tailed P-value &#x3c;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Participants&#x2019; characteristics</title>
<p>In total, 59,842 participants were recruited for this study from 2007-2018. After applying the inclusion and exclusion criteria, 12,498 participants were included (<xref ref-type="fig" rid="F1">Figure 1</xref>). A thorough and comprehensive outline of the baseline characteristics of participants is displayed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Baseline characteristics of study participants by metabolic health and BMI categories, NHANES 2007-2018 (weighted).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Characteristics</th>
<th colspan="3" align="left">Metabolically healthy</th>
<th colspan="4" align="left">Metabolically unhealthy</th>
</tr>
<tr>
<th align="left">MHN</th>
<th align="left">MHOW</th>
<th align="left">MHO</th>
<th align="left">MUN</th>
<th align="left">MUOW</th>
<th align="left">MUO</th>
<th align="left">P</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Number(n)</td>
<td align="left">3,113</td>
<td align="left">2,582</td>
<td align="left">1,564</td>
<td align="left">394</td>
<td align="left">1,619</td>
<td align="left">3,226</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Age</td>
<td align="left">43.7 &#xb1; 17.1</td>
<td align="left">45.1 &#xb1; 15.7</td>
<td align="left">42.3 &#xb1; 15.1</td>
<td align="left">58.6 &#xb1; 15.5</td>
<td align="left">56.7 &#xb1; 15.0</td>
<td align="left">51.8 &#xb1; 15.0</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td colspan="8" align="left">Sex (N/%)</td>
</tr>
<tr>
<td align="left">  MALE</td>
<td align="left">1,371 (44.0%)</td>
<td align="left">1,495 (57.9%)</td>
<td align="left">668 (42.7%)</td>
<td align="left">150 (38.1%)</td>
<td align="left">845 (52.2%)</td>
<td align="left">1,561 (48.4%)</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">  FEMALE</td>
<td align="left">1742 (56.0%)</td>
<td align="left">1,087 (42.1%)</td>
<td align="left">896 (57.3%)</td>
<td align="left">244 (61.9%)</td>
<td align="left">774 (47.8%)</td>
<td align="left">1,665 (51.6%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Race(N/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Mexican American</td>
<td align="left">169 (5.4%)</td>
<td align="left">253 (9.8%)</td>
<td align="left">174 (11.2%)</td>
<td align="left">15 (3.7%)</td>
<td align="left">133 (8.2%)</td>
<td align="left">300 (9.3%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-Hispanic Black</td>
<td align="left">147 (4.7%)</td>
<td align="left">166 (6.4%)</td>
<td align="left">116 (7.2%)</td>
<td align="left">14 (3.6%)</td>
<td align="left">93 (5.7%)</td>
<td align="left">158 (4.9%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-Hispanic White</td>
<td align="left">2,172 (69.8%)</td>
<td align="left">1740 (67.4%)</td>
<td align="left">936 (59.9%)</td>
<td align="left">277 (70.5%)</td>
<td align="left">1,182 (73.0%)</td>
<td align="left">2,251 (69.8%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Other Hispanic</td>
<td align="left">258 (8.3%)</td>
<td align="left">253 (9.8%)</td>
<td align="left">266 (17.1%)</td>
<td align="left">30 (7.5%)</td>
<td align="left">105 (6.5%)</td>
<td align="left">352 (10.9%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Other race</td>
<td align="left">367 (11.8%)</td>
<td align="left">170 (6.6%)</td>
<td align="left">72 (4.6%)</td>
<td align="left">58 (14.7%)</td>
<td align="left">108 (6.7%)</td>
<td align="left">165 (5.1%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Education level (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Lower than 12th grade</td>
<td align="left">392 (12.6%)</td>
<td align="left">361 (14.0%)</td>
<td align="left">222 (14.2%)</td>
<td align="left">93 (23.6%)</td>
<td align="left">288 (17.8%)</td>
<td align="left">584 (18.1%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;High school grade</td>
<td align="left">616 (19.8%)</td>
<td align="left">496 (19.2%)</td>
<td align="left">341 (21.8%)</td>
<td align="left">104 (26.5%)</td>
<td align="left">455 (28.1%)</td>
<td align="left">813 (25.2%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;College grade</td>
<td align="left">2,105 (67.6%)</td>
<td align="left">1725 (66.8%)</td>
<td align="left">1,001 (64.0%)</td>
<td align="left">197 (49.9%)</td>
<td align="left">876 (54.1%)</td>
<td align="left">1829 (56.7%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Family income-to-poverty ratio (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;&#x3c;1.3</td>
<td align="left">623 (20.0%)</td>
<td align="left">503 (19.5%)</td>
<td align="left">357 (22.8%)</td>
<td align="left">93 (23.6%)</td>
<td align="left">351 (21.7%)</td>
<td align="left">742 (23.0%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2265;1.3, &#x3c;3.5</td>
<td align="left">1,046 (33.6%)</td>
<td align="left">865 (33.5%)</td>
<td align="left">638 (40.8%)</td>
<td align="left">154 (39.2%)</td>
<td align="left">619 (38.2%)</td>
<td align="left">1,200 (37.2%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2265;3.5</td>
<td align="left">1,444 (46.4%)</td>
<td align="left">1,214 (47.0%)</td>
<td align="left">569 (36.4%)</td>
<td align="left">147 (37.2%)</td>
<td align="left">649 (40.1%)</td>
<td align="left">1,284 (39.8%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">BMI (kg/m<sup>2</sup>)</td>
<td align="left">22.4 &#xb1; 1.7</td>
<td align="left">27.2 &#xb1; 1.4</td>
<td align="left">34.9 &#xb1; 4.8</td>
<td align="left">23.3 &#xb1; 1.3</td>
<td align="left">27.8 &#xb1; 1.4</td>
<td align="left">36.5 &#xb1; 5.9</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">HDL-C (mmol/L)</td>
<td align="left">1.6 &#xb1; 0.4</td>
<td align="left">1.5 &#xb1; 0.4</td>
<td align="left">1.4 &#xb1; 0.3</td>
<td align="left">1.3 &#xb1; 0.4</td>
<td align="left">1.3 &#xb1; 0.4</td>
<td align="left">1.2 &#xb1; 0.3</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">Waist circumference (cm)</td>
<td align="left">82.8 &#xb1; 7.1</td>
<td align="left">95.0 &#xb1; 6.6</td>
<td align="left">110.8 &#xb1; 11.8</td>
<td align="left">89.9 &#xb1; 6.5</td>
<td align="left">100.7 &#xb1; 6.5</td>
<td align="left">117.4 &#xb1; 13.0</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">Triglycerides (mmol/L)</td>
<td align="left">1.0 &#xb1; 0.5</td>
<td align="left">1.2 &#xb1; 0.7</td>
<td align="left">1.1 &#xb1; 0.5</td>
<td align="left">1.9 &#xb1; 1.1</td>
<td align="left">2.1 &#xb1; 1.7</td>
<td align="left">1.9 &#xb1; 1.6</td>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">Smoking history (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Smoker</td>
<td align="left">1,311 (42.1%)</td>
<td align="left">1,084 (42.0%)</td>
<td align="left">610 (39.0%)</td>
<td align="left">216 (54.8%)</td>
<td align="left">869 (53.7%)</td>
<td align="left">1,542 (47.8%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-smoker</td>
<td align="left">1802 (57.9%)</td>
<td align="left">1,498 (58.0%)</td>
<td align="left">954 (61.0%)</td>
<td align="left">178 (45.2%)</td>
<td align="left">750 (46.3%)</td>
<td align="left">1,684 (52.2%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Physical activity (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">2,497 (80.2%)</td>
<td align="left">2053 (79.5%)</td>
<td align="left">1,176 (75.2%)</td>
<td align="left">241 (61.2%)</td>
<td align="left">1,115 (68.9%)</td>
<td align="left">2,132 (66.1%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">616 (19.8%)</td>
<td align="left">529 (20.5%)</td>
<td align="left">388 (24.8%)</td>
<td align="left">153 (38.8%)</td>
<td align="left">504 (31.1%)</td>
<td align="left">1,094 (33.9%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Diabetes mellitus (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">62 (2.0%)</td>
<td align="left">88 (3.4%)</td>
<td align="left">39 (2.5%)</td>
<td align="left">71 (17.9%)</td>
<td align="left">264 (16.3%)</td>
<td align="left">742 (23.0%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">3,051 (98.0%)</td>
<td align="left">2,494 (96.6%)</td>
<td align="left">1,525 (97.5%)</td>
<td align="left">323 (82.1%)</td>
<td align="left">1,355 (83.7%)</td>
<td align="left">2,484 (77.0%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Hypertension (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">467 (15.0%)</td>
<td align="left">524 (20.3%)</td>
<td align="left">291 (18.6%)</td>
<td align="left">198 (50.3%)</td>
<td align="left">902 (55.7%)</td>
<td align="left">1939 (60.1%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">2,646 (85.0%)</td>
<td align="left">2058 (79.7%)</td>
<td align="left">1,273 (81.4%)</td>
<td align="left">196 (49.7%)</td>
<td align="left">717 (44.3%)</td>
<td align="left">1,287 (39.9%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Coronary heart disease (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">84 (2.7%)</td>
<td align="left">54 (2.1%)</td>
<td align="left">23 (1.5%)</td>
<td align="left">30 (7.6%)</td>
<td align="left">91 (5.6%)</td>
<td align="left">174 (5.4%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">3,029 (97.3%)</td>
<td align="left">2,528 (97.9%)</td>
<td align="left">1,541 (98.5%)</td>
<td align="left">364 (92.4%)</td>
<td align="left">1,528 (94.4%)</td>
<td align="left">3,052 (94.6%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Gout (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">44 (1.4%)</td>
<td align="left">65 (2.5%)</td>
<td align="left">38 (2.4%)</td>
<td align="left">19 (4.8%)</td>
<td align="left">87 (5.4%)</td>
<td align="left">271 (8.4%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">3,049 (98.6%)</td>
<td align="left">2,517 (97.5%)</td>
<td align="left">1,526 (97.6%)</td>
<td align="left">375 (95.2%)</td>
<td align="left">1,532 (94.6%)</td>
<td align="left">2,955 (91.6%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Kidney stone history (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">P &#x3c; 0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">196 (6.3%)</td>
<td align="left">207 (8.0%)</td>
<td align="left">174 (11.1%)</td>
<td align="left">32 (8.1%)</td>
<td align="left">199 (12.3%)</td>
<td align="left">468 (14.5%)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">2,917 (93.7%)</td>
<td align="left">2,375 (92.0%)</td>
<td align="left">1,390 (88.9%)</td>
<td align="left">362 (91.9%)</td>
<td align="left">1,420 (87.7%)</td>
<td align="left">2,758 (85.5%)</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Among the 12,498 participants, 5,239 were metabolically unhealthy, and 7,259 were metabolically healthy. Of the 7,259 metabolically healthy individuals, 3,534 (48.68%) were male, and 3,725 (51.32%) were female. Among the 5,239 metabolically unhealthy participants, 2,556 (48.79%) were male, and 2,683 (51.21%) were female. Among metabolically healthy participants, 3,113 (42.9%) had normal weight, while only 394 (7.5%) participants with normal weight were metabolically unhealthy. In addition, metabolically healthy participants had higher education levels and higher FIRs, were younger, and suffered from a lower risk of coronary heart disease and gout. They also reported higher levels of physical activity.</p>
<p>The overall prevalence of kidney stones was 10.20% among all participants. In each BMI category, the prevalence of kidney stones was higher among metabolically unhealthy participants compared to metabolically healthy participants: normal weight (8.1% vs. 6.3%), overweight (12.3% vs. 8.0%), and obesity (14.5% vs. 11.1%) (P &#x3c; 0.001). Furthermore, in each BMI category, participation in physical activity was more evident among metabolically healthy participants compared to metabolically unhealthy participants: normal weight (80.2% vs. 61.2%), overweight (79.5% vs. 68.9%), and obesity (75.2% vs. 66.1%) (P &#x3c; 0.001).</p>
</sec>
<sec id="s3-2">
<title>3.2 Logistic regression analysis of kidney stone risk</title>
<p>Using the MHN group as a reference, we employed a weighted logistic regression model to determine the association between MHO and kidney stones. In univariate analysis (Model 1), among physically active individuals, the risk of kidney stones was 83% higher in the MHO group compared to the MHN group (OR &#x3d; 1.83, 95% CI: 1.29&#x2013;2.59, P &#x3d; 0.001). The MUN group exhibited a 22% higher risk than the MHN group (OR &#x3d; 1.22, 95% CI: 0.64&#x2013;2.33, P &#x3d; 0.554), while the MUO group exhibited a 130% increased risk (OR &#x3d; 2.30, 95% CI: 1.72&#x2013;3.07, P &#x3c; 0.001). After adjusting for covariates in Model 2 (MHO: OR &#x3d; 2.04, 95% CI: 1.43&#x2013;2.91, P &#x3c; 0.001; MUO: OR &#x3d; 2.08, 95% CI: 1.55&#x2013;2.80, P &#x3c; 0.001) and Model 3 (MHO: OR &#x3d; 2.10, 95% CI: 1.47&#x2013;2.98, P &#x3c; 0.001; MUO: OR &#x3d; 1.98, 95% CI: 1.45&#x2013;2.67, P &#x3c; 0.001), MHO and MUO were still significantly associated with the risk of kidney stones. Interestingly, among participants who did not participate in physical activities, the risk of kidney stones was increased in the MHO group (OR &#x3d; 1.98, 95% CI: 1.10&#x2013;3.60, P &#x3d; 0.025) and the MUO group (OR &#x3d; 3.10, 95% CI: 1.95&#x2013;4.92, P &#x3c; 0.001) compared to the MHN group. Adjustments in Model 2 (MHO: OR &#x3d; 2.27, 95% CI: 1.24&#x2013;4.16, P &#x3d; 0.008; MUO: OR &#x3d; 2.71, 95% CI: 1.69&#x2013;4.34, P &#x3c; 0.001) and Model 3 (MHO: OR &#x3d; 2.22, 95% CI: 1.23&#x2013;4.05, P &#x3d; 0.007; MUO: OR &#x3d; 2.88, 95% CI: 1.83&#x2013;4.52, P &#x3c; 0.001) did not change these significant associations (<xref ref-type="table" rid="T2">Table 2</xref>). Furthermore, the prevalence of kidney stones tends to increase with increasing body weight.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Association between Metabolic-BMI categories and kidney stones, stratified by physical activity status (weighted).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Physical activity</th>
<th colspan="3" align="center">Metabolically healthy</th>
<th colspan="3" align="center">Metabolically unhealthy</th>
</tr>
<tr>
<th align="left">MHN<break/>(OR, 95%Cl), P</th>
<th align="left">MHOW<break/>(OR, 95%Cl), P</th>
<th align="left">MHO<break/>(OR, 95%Cl), P</th>
<th align="left">MUN<break/>(OR, 95%Cl), P</th>
<th align="left">MUOW<break/>(OR, 95%Cl), P</th>
<th align="left">MUO<break/>(OR, 95%Cl), P</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="7" align="left">Yes</td>
</tr>
<tr>
<td align="left">&#x2003;Model 1</td>
<td align="left">Reference</td>
<td align="left">1.31 (0.96&#x2013;1.78), 0.088</td>
<td align="left">1.83 (1.29&#x2013;2.59), 0.001</td>
<td align="left">1.22 (0.64&#x2013;2.33), 0.554</td>
<td align="left">2.08 (1.47&#x2013;2.94), &#x3c;0.001</td>
<td align="left">2.30 (1.72&#x2013;3.07), &#x3c;0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Model 2</td>
<td align="left">Reference</td>
<td align="left">1.27 (0.93&#x2013;1.74), 0.131</td>
<td align="left">2.04 (1.43&#x2013;2.91), &#x3c;0.001</td>
<td align="left">0.96 (0.50&#x2013;1.86), 0.906</td>
<td align="left">1.63 (1.14&#x2013;2.34), 0.008</td>
<td align="left">2.08 (1.55&#x2013;2.80), &#x3c;0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Model 3</td>
<td align="left">Reference</td>
<td align="left">1.29 (0.94&#x2013;1.71), 0.129</td>
<td align="left">2.10 (1.47&#x2013;2.98), &#x3c;0.001</td>
<td align="left">0.93 (0.49&#x2013;1.85), 0.875</td>
<td align="left">1.61 (1.09&#x2013;2.31), 0.007</td>
<td align="left">1.98 (1.45&#x2013;2.67), &#x3c;0.001</td>
</tr>
<tr>
<td colspan="7" align="left">No</td>
</tr>
<tr>
<td align="left">&#x2003;Model 1</td>
<td align="left">Reference</td>
<td align="left">1.29 (0.72&#x2013;2.30), 0.391</td>
<td align="left">1.98 (1.10&#x2013;3.60), 0.025</td>
<td align="left">1.51 (0.74&#x2013;3.10), 0.261</td>
<td align="left">2.15 (1.27&#x2013;3.64), 0.005</td>
<td align="left">3.10 (1.95&#x2013;4.92), &#x3c;0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Model 2</td>
<td align="left">Reference</td>
<td align="left">1.24 (0.70&#x2013;2.20), 0.462</td>
<td align="left">2.27 (1.24&#x2013;4.16), 0.008</td>
<td align="left">1.21 (0.58&#x2013;2.53), 0.618</td>
<td align="left">1.67 (0.97&#x2013;2.90), 0.066</td>
<td align="left">2.71 (1.69&#x2013;4.34), &#x3c;0.001</td>
</tr>
<tr>
<td align="left">&#x2003;Model 3</td>
<td align="left">Reference</td>
<td align="left">1.25 (0.71&#x2013;2.19), 0.452</td>
<td align="left">2.22 (1.23&#x2013;4.05), 0.007</td>
<td align="left">1.24 (0.61&#x2013;2.62), 0.558</td>
<td align="left">1.72 (0.99&#x2013;2.89), 0.049</td>
<td align="left">2.88 (1.83&#x2013;4.52), &#x3c;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Model 1: Unadjusted.</p>
</fn>
<fn>
<p>Model 2: Adjusted for age, sex, race.</p>
</fn>
<fn>
<p>Model 3: Additionally adjusted for education level, FIR, smoking status, coronary heart disease (Excluding physical activities).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-3">
<title>3.3 Subgroup analysis</title>
<p>Additional stratified logistic regression and interaction effect analyses were conducted among participants involved in physical activities to identify variables that may modify the association between MHO and kidney stones. Formal tests for interaction revealed that age (P-interaction &#x3d; 0.451), sex (P-interaction &#x3d; 0.266), and race (P-interaction &#x3d; 0.225) did not significantly affect the association between MHO and kidney stones. Similarly, no significant interaction effects were found for education level (P-interaction &#x3d; 0.140), family income-to-poverty ratio (P-interaction &#x3d; 0.416), smoking history (P-interaction &#x3d; 0.661), diabetes mellitus (P-interaction &#x3d; 0.202), hypertension (P-interaction &#x3d; 0.940), coronary heart disease (P-interaction &#x3d; 0.193), or gout (P-interaction &#x3d; 0.587) (<xref ref-type="table" rid="T3">Table 3</xref>). We also assessed the association between participation in physical activity and the presence of kidney stones. Among most metabolic-BMI groups, individuals who engaged in physical activity were at a lower risk of kidney stones compared to inactive individuals (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Tests for interaction: Association between Metabolic-BMI categories and kidney stones within physical activity subgroup, stratified by covariates (weighted).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Characteristics</th>
<th colspan="3" align="center">Metabolically healthy</th>
<th colspan="4" align="left">Metabolically unhealthy</th>
</tr>
<tr>
<th align="left">MHN<break/>(OR, 95%Cl)</th>
<th align="left">MHOW<break/>(OR, 95%Cl)</th>
<th align="left">MHO<break/>(OR, 95%Cl)</th>
<th align="left">MUN<break/>(OR, 95%Cl)</th>
<th align="left">MUOW<break/>(OR, 95%Cl)</th>
<th align="left">MUO<break/>(OR, 95%Cl)</th>
<th align="left">P- interaction</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Age (N/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.451</td>
</tr>
<tr>
<td align="left">&#x2003;20-39</td>
<td align="left">Reference</td>
<td align="left">1.62 (1.00&#x2013;2.64)</td>
<td align="left">1.34 (0.77&#x2013;2.32)</td>
<td align="left">2.51 (0.66&#x2013;9.56)</td>
<td align="left">2.65 (1.32&#x2013;5.35)</td>
<td align="left">1.77 (1.06&#x2013;2.95)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;40-59</td>
<td align="left">Reference</td>
<td align="left">1.17 (0.68&#x2013;2.02</td>
<td align="left">2.81 (1.61&#x2013;4.91)</td>
<td align="left">0.51 (0.12&#x2013;2.26)</td>
<td align="left">1.76 (0.97&#x2013;3.21)</td>
<td align="left">2.15 (1.33&#x2013;3.50)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;60-80</td>
<td align="left">Reference</td>
<td align="left">1.06 (0.61&#x2013;1.85</td>
<td align="left">1.55 (0.69&#x2013;3.44)</td>
<td align="left">0.97 (0.41&#x2013;2.29)</td>
<td align="left">1.41 (0.82&#x2013;2.44)</td>
<td align="left">2.01 (1.20&#x2013;3.39)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Sex (N/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.266</td>
</tr>
<tr>
<td align="left">  MALE</td>
<td align="left">Reference</td>
<td align="left">1.16 (0.77&#x2013;1.76)</td>
<td align="left">1.82 (1.09&#x2013;3.03)</td>
<td align="left">0.48 (0.14&#x2013;1.67)</td>
<td align="left">1.87 (1.18&#x2013;2.96)</td>
<td align="left">1.98 (1.32&#x2013;2.96)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">  FEMALE</td>
<td align="left">Reference</td>
<td align="left">1.39 (0.87&#x2013;2.21)</td>
<td align="left">1.83 (1.14&#x2013;2.92)</td>
<td align="left">2.17 (0.99&#x2013;4.73)</td>
<td align="left">2.22 (1.31&#x2013;3.76)</td>
<td align="left">2.64 (1.71&#x2013;3.99)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Race(N/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.225</td>
</tr>
<tr>
<td align="left">&#x2003;Mexican American</td>
<td align="left">Reference</td>
<td align="left">1.64 (0.69&#x2013;3.92)</td>
<td align="left">2.35 (0.88&#x2013;6.28)</td>
<td align="left">1.00 (0.70&#x2013;1.50)</td>
<td align="left">3.77 (1.56&#x2013;9.11)</td>
<td align="left">2.22 (0.95&#x2013;5.15)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-Hispanic Black</td>
<td align="left">Reference</td>
<td align="left">2.66 (1.16&#x2013;6.11)</td>
<td align="left">1.97 (0.76&#x2013;5.08)</td>
<td align="left">3.78 (0.83&#x2013;17.08)</td>
<td align="left">1.27 (0.43&#x2013;3.78)</td>
<td align="left">2.92 (1.29&#x2013;6.62)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-Hispanic White</td>
<td align="left">Reference</td>
<td align="left">1.30 (0.89&#x2013;1.89)</td>
<td align="left">2.07 (1.34&#x2013;3.19)</td>
<td align="left">1.23 (0.57&#x2013;2.64)</td>
<td align="left">2.07 (1.37&#x2013;3.11)</td>
<td align="left">2.27 (1.60&#x2013;3.22)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Other Hispanic</td>
<td align="left">Reference</td>
<td align="left">0.92 (0.42&#x2013;2.05)</td>
<td align="left">1.28 (0.61&#x2013;2.73)</td>
<td align="left">0.64 (0.08&#x2013;5.17)</td>
<td align="left">2.17 (0.87&#x2013;5.40)</td>
<td align="left">1.64 (0.81&#x2013;3.33)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Other race</td>
<td align="left">Reference</td>
<td align="left">1.19 (0.46&#x2013;3.10)</td>
<td align="left">1.64 (0.51&#x2013;5.28)</td>
<td align="left">0.86 (0.18&#x2013;4.18)</td>
<td align="left">1.43 (0.45&#x2013;4.51)</td>
<td align="left">5.32 (2.34&#x2013;12.08)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Education level (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.140</td>
</tr>
<tr>
<td align="left">&#x2003;Lower than 12th grade</td>
<td align="left">Reference</td>
<td align="left">1.18 (0.58&#x2013;2.40)</td>
<td align="left">1.35 (0.54&#x2013;3.35)</td>
<td align="left">0.53 (0.13&#x2013;2.22)</td>
<td align="left">1.52 (0.71&#x2013;3.27)</td>
<td align="left">1.46 (0.76&#x2013;2.81)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;High school grade</td>
<td align="left">Reference</td>
<td align="left">0.81 (0.40&#x2013;1.64)</td>
<td align="left">1.97 (0.96&#x2013;4.06)</td>
<td align="left">1.11 (0.35&#x2013;3.53)</td>
<td align="left">1.24 (0.58&#x2013;2.66)</td>
<td align="left">1.65 (0.88&#x2013;3.12)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;College grade</td>
<td align="left">Reference</td>
<td align="left">1.51 (1.03&#x2013;2.21)</td>
<td align="left">1.87 (1.19&#x2013;2.92)</td>
<td align="left">1.54 (0.62&#x2013;3.83)</td>
<td align="left">2.66 (1.72&#x2013;4.13)</td>
<td align="left">2.80 (1.94&#x2013;4.05)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Family income-to-poverty ratio (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.416</td>
</tr>
<tr>
<td align="left">&#x2003;&#x3c;1.3</td>
<td align="left">Reference</td>
<td align="left">1.47 (0.85&#x2013;2.55)</td>
<td align="left">2.25 (1.26&#x2013;4.03)</td>
<td align="left">1.35 (0.47&#x2013;3.82)</td>
<td align="left">2.12 (1.20&#x2013;3.74)</td>
<td align="left">2.08 (1.28&#x2013;3.37)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2265;1.3, &#x3c;3.5</td>
<td align="left">Reference</td>
<td align="left">1.09 (0.65&#x2013;1.83)</td>
<td align="left">1.25 (0.70&#x2013;2.24)</td>
<td align="left">0.81 (0.30&#x2013;2.19)</td>
<td align="left">1.83 (1.02&#x2013;3.29)</td>
<td align="left">1.78 (1.12&#x2013;2.84)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;&#x2265;3.5</td>
<td align="left">Reference</td>
<td align="left">1.42 (0.88&#x2013;2.28)</td>
<td align="left">2.27 (1.28&#x2013;4.01)</td>
<td align="left">1.57 (0.54&#x2013;4.54)</td>
<td align="left">2.26 (1.33&#x2013;3.85)</td>
<td align="left">2.90 (1.83&#x2013;4.60)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Smoking history (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.661</td>
</tr>
<tr>
<td align="left">&#x2003;Smoker</td>
<td align="left">Reference</td>
<td align="left">1.17 (0.75&#x2013;1.83)</td>
<td align="left">1.81 (1.07&#x2013;3.08)</td>
<td align="left">1.11 (0.46&#x2013;2.70)</td>
<td align="left">1.91 (1.16&#x2013;3.13)</td>
<td align="left">2.23 (1.46&#x2013;3.40)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;Non-smoker</td>
<td align="left">Reference</td>
<td align="left">1.42 (0.93&#x2013;2.17)</td>
<td align="left">1.86 (1.17&#x2013;2.96)</td>
<td align="left">1.30 (0.50&#x2013;3.34)</td>
<td align="left">2.21 (1.37&#x2013;3.57)</td>
<td align="left">2.32 (1.56&#x2013;3.46)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Diabetes mellitus (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.202</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">Reference</td>
<td align="left">0.93 (0.28&#x2013;3.07)</td>
<td align="left">6.11 (1.23&#x2013;30.44)</td>
<td align="left">4.13 (1.10&#x2013;15.48)</td>
<td align="left">2.59 (0.87&#x2013;7.70)</td>
<td align="left">3.79 (1.37&#x2013;10.46)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">Reference</td>
<td align="left">1.32 (0.97&#x2013;1.80)</td>
<td align="left">1.75 (1.23&#x2013;2.50)</td>
<td align="left">0.83 (0.35&#x2013;2.00)</td>
<td align="left">2.01 (1.38&#x2013;2.92)</td>
<td align="left">2.00 (1.46&#x2013;2.74)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Hypertension (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.940</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">Reference</td>
<td align="left">1.29 (0.71&#x2013;2.32)</td>
<td align="left">1.37 (0.64&#x2013;2.87)</td>
<td align="left">1.51 (0.65&#x2013;3.50)</td>
<td align="left">1.75 (1.01&#x2013;3.02)</td>
<td align="left">1.89 (1.15&#x2013;3.12)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">Reference</td>
<td align="left">1.26 (0.88&#x2013;1.81)</td>
<td align="left">1.93 (1.30&#x2013;2.86)</td>
<td align="left">0.39 (0.13&#x2013;1.15)</td>
<td align="left">1.16 (0.99&#x2013;2.83)</td>
<td align="left">1.82 (1.21&#x2013;2.73)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Coronary heart disease (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.193</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">Reference</td>
<td align="left">0.91 (0.23&#x2013;3.57)</td>
<td align="left">2.07 (0.24&#x2013;17.97)</td>
<td align="left">2.06 (0.40&#x2013;10.75)</td>
<td align="left">2.53 (0.73&#x2013;8.83)</td>
<td align="left">3.27 (1.10&#x2013;9.69)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">Reference</td>
<td align="left">1.32 (0.96&#x2013;1.80)</td>
<td align="left">1.83 (1.28&#x2013;2.61)</td>
<td align="left">1.11 (0.54&#x2013;2.27)</td>
<td align="left">2.05 (1.43&#x2013;2.92)</td>
<td align="left">2.24 (1.66&#x2013;3.02)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Gout (n/%)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">0.587</td>
</tr>
<tr>
<td align="left">&#x2003;Yes</td>
<td align="left">Reference</td>
<td align="left">0.48 (0.14&#x2013;1.69)</td>
<td align="left">0.49 (0.08&#x2013;3.10)</td>
<td align="left">0.59 (0.10&#x2013;3.54)</td>
<td align="left">0.33 (0.09&#x2013;1.18)</td>
<td align="left">0.93 (0.32&#x2013;2.67)</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2003;No</td>
<td align="left">Reference</td>
<td align="left">1.33 (0.97&#x2013;1.83)</td>
<td align="left">1.89 (1.32&#x2013;2.70)</td>
<td align="left">1.19 (0.60&#x2013;2.38)</td>
<td align="left">2.18 (1.53&#x2013;3.11)</td>
<td align="left">2.18 (1.61&#x2013;2.94)</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The prevalence of kidney stones among participants in different groups after adjustment. Orange indicates participants without physical activity. Blue indicates participants with physical activity. (MHN, metabolically healthy normal weight; MHOW, metabolically healthy overweight; MHO, metabolically healthy obesity; MUN, metabolically unhealthy normal weight; MUOW, metabolically unhealthy overweight; MUO, metabolically unhealthy obesity).</p>
</caption>
<graphic xlink:href="fphys-16-1625100-g002.tif">
<alt-text content-type="machine-generated">Line graph comparing the adjusted percentage of kidney stones across different metabolically healthy obesity categories, with &#x201c;Yes&#x201d; in blue and &#x201c;No&#x201d; in orange. The orange line remains above the blue line, showing an increasing trend. Categories include MHN, MHOW, MHO, MUN, MUOW, and MUO.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this cross-sectional study, we explored the association between obesity and kidney stones among participants aged 20 years and older. In particular, we compared those with metabolically healthy profiles to those with metabolically unhealthy conditions. According to weighted analysis, the incidence of kidney stones was 10.20% among individuals aged 20 and older, which is close to the reported kidney stone prevalence of 9.6% in the U.S. (<xref ref-type="bibr" rid="B15">Mao et al., 2021</xref>; <xref ref-type="bibr" rid="B1">Abufaraj et al., 2021</xref>).</p>
<p>Our understanding of the pathogenesis of nephrolithiasis is gradually evolving, shifting from a standalone condition to one with systemic implications. Recent studies have indicated that various metabolic factors, including obesity, diabetes, and metabolic syndrome, play a crucial role in the development of kidney stones (<xref ref-type="bibr" rid="B24">Skolarikos et al., 2024</xref>; <xref ref-type="bibr" rid="B23">Singh et al., 2022</xref>). The precise mechanisms linking obesity and metabolic syndrome to nephrolithiasis remain incompletely understood, although several metabolic factors have been implicated. These factors include increased urinary excretion of uric acid and oxalate. Hyperinsulinemia can lead to hypercalciuria, and insulin resistance reduces renal ammonium production and hypocitraturia (<xref ref-type="bibr" rid="B14">Lo et al., 2023</xref>; <xref ref-type="bibr" rid="B9">Faggiano et al., 2003</xref>). Additionally, hypertension may make urinary composition conducive to stone formation, and vascular damage may impair medullary blood flow (<xref ref-type="bibr" rid="B26">Wang et al., 2021</xref>). Obesity is also associated with altered serum levels of calcium, phosphate, vitamin D, and uric acid, all of which may affect the risk of nephrolithiasis. Moreover, obesity upregulates systemic inflammatory markers in the blood, and inflammation is believed to increase the risk of developing kidney stones (<xref ref-type="bibr" rid="B4">Amin et al., 2018</xref>). In the present study, we measured the associations between metabolic abnormalities, obesity, and nephrolithiasis based on data from NHANES. Our findings reveal that irrespective of the presence of MHO or metabolically unhealthy obesity, the prevalence of kidney stones increases with BMI. Even in the presence of a normal metabolic profile, a significant independent association persists between obesity and kidney stone disease. Dietary patterns of individuals with obesity, often characterized by high caloric intake and increased consumption of animal proteins (<xref ref-type="bibr" rid="B28">Westbury et al., 2023</xref>), may lower urinary pH and increase uric acid excretion, thereby increasing the risk of nephrolithiasis (<xref ref-type="bibr" rid="B25">Thongprayoon et al., 2020</xref>). In addition, obesity may heighten the risk of nephrolithiasis by altering serum calcium concentrations (<xref ref-type="bibr" rid="B14">Lo et al., 2023</xref>). Physical activity serves as a protective factor against the development of kidney stones and has beneficial effects on glucose and lipid metabolism and blood pressure, thereby preserving cardiovascular function (<xref ref-type="bibr" rid="B20">Oja et al., 2024</xref>; <xref ref-type="bibr" rid="B5">Canela et al., 2023</xref>). We conducted subgroup analyses based on physical activity status. Our subgroup analysis indicated that physical activity is associated with a reduced risk of kidney stones, particularly among metabolically unhealthy individuals. The underlying mechanisms are likely multifaceted. First, physical activity can alleviate insulin resistance, thereby reducing the urinary excretion of uric acid, calcium, and phosphorus, major constituents of most stones (<xref ref-type="bibr" rid="B27">Weinberg et al., 2014</xref>). Second, transient dehydration caused by physical activity can enhance the release of arginine vasopressin, which promotes thirst. Higher water intake in response to thirst compensates for fluid loss, increases urine output, and dilutes stone-forming substances, thereby preventing stone formation (<xref ref-type="bibr" rid="B19">Mora-Rodriguez et al., 2016</xref>). Moreover, physical activity can affect the gut microbiome via multiple pathways, which in turn may reduce urinary oxalate excretion by modulating gastrointestinal oxalate metabolism, thereby preventing the formation of kidney stones (<xref ref-type="bibr" rid="B6">Chmiel et al., 2023</xref>). Although the associations between obesity, metabolic syndrome, and kidney stones have been established, the specific role of the MHO phenotype and the modifying effect of physical activity in these relationships did not receive sufficient attention. Our findings suggest that among metabolically unhealthy individuals, higher levels of physical activity are associated with a substantially lower risk of nephrolithiasis. These findings support recommendations for a higher level of physical activity, particularly among metabolically unhealthy individuals with low levels of activity.</p>
<p>To our knowledge, this is the first study to specifically investigate the association between MHO and kidney stone disease and assess the potential modifying role of physical activity. Our findings suggested that physical activity may decrease the increased risk of kidney stone formation associated with metabolically unhealthy obesity. Several limitations of this study should be acknowledged. Primarily, the cross-sectional nature of this study limited our ability to definitively establish a cause-and-effect link between MHO and kidney stone disease, highlighting the need for future longitudinal studies to validate these findings and provide deeper insights into their temporal patterns. Second, reliance on self-reported histories of kidney stones may overlook asymptomatic cases or introduce recall bias. Third, metabolic health status is dynamic and MHO may shift to MUO, but this study assessed it at a single time point, potentially misclassifying some individuals. Fourth, the lack of stratification by activity intensity (e.g., moderate vs. vigorous) or activity duration prevented dose-response analyses. Additionally, the NHANES dataset lacks information on stone composition (e.g., uric acid or calcium oxalate); therefore, we could not investigate the associations between obesity and specific stone types. Finally, despite adjustments for multiple covariates, residual confounding from factors such as dietary patterns or genetic predisposition might still affect the findings. Future studies should incorporate dynamic metabolic monitoring (e.g., continuous glucose tracking) and urinary biomarker analyses to elucidate the mechanisms linking metabolism, and obesity to nephrolithiasis, whereas clinical trials are needed to validate the efficacy of preventive strategies.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>This cross-sectional study revealed significant associations of both MHO and unhealthy obesity with nephrolithiasis, suggesting that obesity itself may be a key factor associated with nephrolithiasis regardless of metabolic status. Notably, higher levels of physical activity were associated with lower risks of nephrolithiasis, particularly among metabolically unhealthy individuals. These findings support the role of physical activity as a potential protective factor, which may act through improved insulin sensitivity, reduced urinary excretion of stone-forming metabolites, and increased hydration. However, the cross-sectional design limits causal inference, and self-reported history of kidney stone may introduce recall bias. Future longitudinal studies with dynamic metabolic monitoring and urinary biomarkers are needed to validate these associations and elucidate the underlying pathways. Clinically, our findings recommend weight loss and physical activity to lower the risk of nephrolithiasis, especially in high-risk individuals with obesity.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>XD: Writing &#x2013; original draft, Writing &#x2013; review and editing. QD: Data curation, Methodology, Supervision, Writing &#x2013; review and editing. JL: Conceptualization, Investigation, Software, Writing &#x2013; review and editing. CJ: Data curation, Investigation, Supervision, Writing &#x2013; review and editing. EZ: Conceptualization, Formal Analysis, Investigation, Writing &#x2013; review and editing. WH: Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2025.1625100/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2025.1625100/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s13">
<title>Abbreviations</title>
<p>MHN, metabolically healthy normal weight; MHOW, metabolically healthy overweight; MHO, metabolically healthy obese; MUN, metabolically unhealthy normal weight; MUOW, metabolically unhealthy overweight; MUO, metabolically unhealthy obese; FIR, family income-to-poverty ratio; CDC, Centers for Disease Control and Prevention; NHANES, National Health and Nutrition Examination Survey; BMI, Body Mass Index; WHO, World Health Organization.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abufaraj</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Waldhoer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>D&#x27;andrea</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007-2018 data</article-title>. <source>Eur. Urol. focus</source> <volume>7</volume> (<issue>6</issue>), <fpage>1468</fpage>&#x2013;<lpage>1475</lpage>. <pub-id pub-id-type="doi">10.1016/j.euf.2020.08.011</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberti</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>Eckel</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Grundy</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Zimmet</surname>
<given-names>P. Z.</given-names>
</name>
<name>
<surname>Cleeman</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>K. A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; World heart federation; international atherosclerosis society; and international association for the study of obesity</article-title>. <source>Circulation</source> <volume>120</volume> (<issue>16</issue>), <fpage>1640</fpage>&#x2013;<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.109.192644</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Fuster</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Dimke</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mechanisms underlying calcium nephrolithiasis</article-title>. <source>Annu. Rev. physiology</source> <volume>84</volume>, <fpage>559</fpage>&#x2013;<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-052521-121822</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Asplin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alshaikh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ratakonda</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria</article-title>. <source>Kidney Int.</source> <volume>93</volume> (<issue>5</issue>), <fpage>1098</fpage>&#x2013;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2017.11.011</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canela</surname>
<given-names>V. H.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lingeman</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>A. R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease</article-title>. <source>Nat. Commun.</source> <volume>14</volume> (<issue>1</issue>), <fpage>4140</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-023-38975-8</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chmiel</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Stuivenberg</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Al</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Akouris</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Razvi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>J. P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Vitamins as regulators of calcium-containing kidney stones - new perspectives on the role of the gut microbiome</article-title>. <source>Nat. Rev. Urol.</source> <volume>20</volume> (<issue>10</issue>), <fpage>615</fpage>&#x2013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1038/s41585-023-00768-5</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kuxhaus</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Stefan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F. B.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>M. B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses&#x27; Health Study): 30 year follow-up from a prospective cohort study</article-title>. <source>lancet Diabetes &#x26; Endocrinol.</source> <volume>6</volume> (<issue>9</issue>), <fpage>714</fpage>&#x2013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1016/s2213-8587(18)30137-2</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elmaleh-Sachs</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Bramante</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Nicklas</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Gudzune</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Jay</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Obesity management in adults: a review</article-title>. <source>Jama</source> <volume>330</volume> (<issue>20</issue>), <fpage>2000</fpage>&#x2013;<lpage>2015</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2023.19897</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faggiano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pivonello</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Melis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Filippella</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Somma</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Petretta</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Nephrolithiasis in Cushing&#x27;s disease: prevalence, etiopathogenesis, and modification after disease cure</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>88</volume> (<issue>5</issue>), <fpage>2076</fpage>&#x2013;<lpage>2080</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2002-021494</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferraro</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Curhan</surname>
<given-names>G. C.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>24-Hour urinary chemistries and kidney stone risk</article-title>. <source>Am. J. kidney Dis. official J. Natl. Kidney Found.</source> <volume>84</volume> (<issue>2</issue>), <fpage>164</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2024.02.010</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Retnakaran</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Are metabolically healthy overweight and obesity benign conditions? a systematic review and meta-analysis</article-title>. <source>Ann. Intern Med.</source> <volume>159</volume> (<issue>11</issue>), <fpage>758</fpage>&#x2013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-159-11-201312030-00008</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Association between daily sitting time and kidney stones based on the National Health and Nutrition Examination Survey (NHANES) 2007-2016: a cross-sectional study</article-title>. <source>Int. J. Surg. Lond. Engl.</source> <volume>110</volume> (<issue>8</issue>), <fpage>4624</fpage>&#x2013;<lpage>4632</lpage>. <pub-id pub-id-type="doi">10.1097/js9.0000000000001560</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Associations between nephrolithiasis and diabetes mellitus, hypertension and gallstones: a meta-analysis of cohort studies</article-title>. <source>Nephrol. Carlt. Vic.</source> <volume>25</volume> (<issue>9</issue>), <fpage>691</fpage>&#x2013;<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1111/nep.13740</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lovegrove</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Be&#x161;evi&#x107;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lacey</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Littlejohns</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>N. E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Central adiposity increases risk of kidney stone disease through effects on serum calcium concentrations</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>34</volume> (<issue>12</issue>), <fpage>1991</fpage>&#x2013;<lpage>2011</lpage>. <pub-id pub-id-type="doi">10.1681/asn.0000000000000238</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Polyfluoroalkyl chemicals and the risk of kidney stones in US adults: a population-based study</article-title>. <source>Ecotoxicol. Environ. Saf.</source> <volume>208</volume>, <fpage>111497</fpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2020.111497</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Physical activity reduces the effect of high body mass index on kidney stones in diabetes participants from the 2007-2018 NHANES cycles: a cross-sectional study</article-title>. <source>Front. public health</source> <volume>10</volume>, <fpage>936552</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2022.936552</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Casagrande</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geiss</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cowie</surname>
<given-names>C. C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Prevalence of and trends in diabetes among adults in the United States, 1988-2012</article-title>. <source>Jama</source> <volume>314</volume> (<issue>10</issue>), <fpage>1021</fpage>&#x2013;<lpage>1029</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.10029</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moftakhar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ghoddusi Johari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rezaeianzadeh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Rezaianzadeh</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Prevalence and risk factors of kidney stone disease in population aged 40-70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran</article-title>. <source>BMC Urol.</source> <volume>22</volume> (<issue>1</issue>), <fpage>205</fpage>. <pub-id pub-id-type="doi">10.1186/s12894-022-01161-x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mora-Rodriguez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ortega</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Fernandez-Elias</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Kapsokefalou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malisova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Athanasatou</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Influence of physical activity and ambient temperature on hydration: the European hydration research study (EHRS)</article-title>. <source>Nutrients</source> <volume>8</volume> (<issue>5</issue>), <fpage>252</fpage>. <pub-id pub-id-type="doi">10.3390/nu8050252</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Memon</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jurakic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Health benefits of different sports: a systematic review and meta-analysis of longitudinal and intervention studies including 2.6 million adult participants</article-title>. <source>Sports Med. - open</source> <volume>10</volume> (<issue>1</issue>), <fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s40798-024-00692-x</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peerapen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thongboonkerd</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Kidney stone prevention</article-title>. <source>Adv. Nutr. (Bethesda, Md)</source> <volume>14</volume> (<issue>3</issue>), <fpage>555</fpage>&#x2013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1016/j.advnut.2023.03.002</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulze</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Stefan</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>20</volume> (<issue>11</issue>), <fpage>633</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-024-01008-5</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Sas</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lieske</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The genetics of kidney stone disease and nephrocalcinosis</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>18</volume> (<issue>4</issue>), <fpage>224</fpage>&#x2013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-021-00513-4</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skolarikos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Somani</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Neisius</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pet&#x159;&#xed;k</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tailly</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Metabolic evaluation and recurrence prevention for urinary stone patients: an EAU guidelines update</article-title>. <source>Eur. Urol.</source> <volume>86</volume> (<issue>4</issue>), <fpage>343</fpage>&#x2013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2024.05.029</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thongprayoon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Krambeck</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Rule</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Determining the true burden of kidney stone disease</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>16</volume> (<issue>12</issue>), <fpage>736</fpage>&#x2013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-020-0320-7</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recent advances on the mechanisms of kidney stone formation (Review)</article-title>. <source>Int. J. Mol. Med.</source> <volume>48</volume> (<issue>2</issue>), <fpage>149</fpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2021.4982</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinberg</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Chertow</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Leppert</surname>
<given-names>J. T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Diabetic severity and risk of kidney stone disease</article-title>. <source>Eur. Urol.</source> <volume>65</volume> (<issue>1</issue>), <fpage>242</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2013.03.026</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westbury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oyebode</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>van Rens</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Obesity stigma: causes, consequences, and potential solutions</article-title>. <source>Curr. Obes. Rep.</source> <volume>12</volume> (<issue>1</issue>), <fpage>10</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1007/s13679-023-00495-3</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roderick</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Somani</surname>
<given-names>B. K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Metabolic syndrome and kidney stone disease: a systematic review of literature</article-title>. <source>J. Endourol.</source> <volume>30</volume> (<issue>3</issue>), <fpage>246</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1089/end.2015.0567</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>